The price of a 100mg bottle of Enmetrizumab is usually around $9,000 to $10,000. The specific price needs to be analyzed according to the local hospital level, the area where the hospital is located, the drug manufacturer and other factors.
Enmetrastuzumab belongs to the drugs targeting HER-2 antibodies, and the indications mainly include the adjuvant treatment of HER2-positive early-stage breast cancer patients with residual invasive lesions after receiving neoadjuvant therapy based on paclitaxel combined with trastuzumab, as well as patients with HER2-positive, unresectable, locally advanced or metastatic breast cancer who have received paclitaxel combined with trastuzumab. –
A 100mg bottle of the drug will cost around $9,000 to $10,000, and the price of the drug may vary depending on the manufacturer, hospital area, drug dosage, and other factors.
During the course of medication, patients may experience a variety of adverse reactions such as diarrhea, vomiting, and nausea. It is contraindicated for those who are allergic to this product or any of its excipients. Liver function should be monitored in patients prior to treatment with this drug and prior to subsequent doses.
The drug needs to be used under the guidance of a clinical professional. If any discomfort occurs during the administration of the drug, it is necessary to promptly inform the attending physician and take corresponding measures to alleviate the situation.